Search
for
Sort by
Research 751–780 of 1000+
- 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION
- The Effect of Anti-Androgens on the Response of Rat Preputial Glands to Testosterone*
- Testosterone Hormone ; Clinical Indications, Dysregulation and Therapeutic methods
- ANTIANDROGENS AND THE SKIN
- Androgenic alopecia and its association with metabolic syndrome
- Steroidogenesis in steroid related cancers
- Androgenetic Alopecia From A to Z
- Ferret adrenal-associated endocrinopathy.
- What are the possible reasons for urethral PSA varieties after radical prostatectomy?
- 5α‐Reductase Inhibitors
- Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- 5α-reductase activity in the prostate
- Alopecia androgénica como factor predictor de hiperplasia benigna de próstata
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
- Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male
- CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT?
- WNT10B (wingless-type MMTV integration site family)
- Androgenic alopecia--Its characteristics and perspectives
- Acute urinary retention: risks and management.
- In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat
- EFFECTS OF FESOTERODINE, A NOVEL ANTIMUSCARINIC, ALONE AND IN COMBINATION WITH AN α-RECEPTOR BLOCKER, DOXAZOSIN, ON BLADDER FUNCTION IN OBSTRUCTED RATS
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
- Ductal breast cancer in a male patient
- The prevention of benign prostatic hyperplasia (bph)
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Why would men use finasteride in 2005?
- Endocrine control of benign prostatic hyperplasia
- Comparison of clinical trials with finasteride and dutasteride.